Definition, Pathogenesis, and Natural Progress of Non-alcoholic Fatty Liver Disease / 임상당뇨병
Journal of Korean Diabetes
;
: 65-70, 2014.
Artículo
en Coreano
| WPRIM
| ID: wpr-726903
ABSTRACT
Non-alcoholic fatty liver disease (NAFLD) is emerging as a world-wide health problem and is currently recognized as a hepatic manifestation of metabolic syndrome. It is an umbrella term to describe a wide range of diseases from simple steatosis to non-alcoholic hepatosteatosis (NASH) and NSAH-related liver cirrhosis. NAFLD is mainly associated with insulin resistance which allows increased free fatty acid (FFA) flux to the liver by increasing lipolysis from adipose tissue, triggering macrophage/immune activation, decreasing skeletal muscle glucose uptake, and increasing de novo lipogenesis. Increased FFA pool in the liver, in turn, increases lipotoxic intermediates, such as ceramides, diacylglycerols, and lysophosphatidylcholines, which are responsible for mitochondrial dysfunction and endoplasmic reticulum stress, resulting in inflammation of the liver. When inflammation is severe enough to affect stellate cells, hepatic fibrosis can be induced.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Fibrosis
/
Resistencia a la Insulina
/
Lisofosfatidilcolinas
/
Ceramidas
/
Tejido Adiposo
/
Músculo Esquelético
/
Diglicéridos
/
Lipogénesis
/
Células Estrelladas Hepáticas
/
Hígado Graso
Tipo de estudio:
Estudio de etiología
Idioma:
Coreano
Revista:
Journal of Korean Diabetes
Año:
2014
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS